Fig. 2From: Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER databaseOverall survival. a OS for patients treated with CRT and CT in whole cohort (N = 922); b OS for patients treated with CRT and CT in IHBDC cohort (N = 139); c OS for patients treated with CRT and CT in EHBDC (N = 364); d OS for patients treated with CRT and CT in GBCA (N = 419). OS: overall survival; CRT: chemoradiotherapy; CT: chemotherapy; BTC: biliary tract cancers; IHBDC: intrahepatic bile duct cancer; EHBDC: extrahepatic bile duct cancer; GBCA: gallbladder cancer (GBCA)Back to article page